Patent Assignment
Reel/Frame 053681/0224
Change of Name
Recorded: 2020-09-03
Pages: 8
Assignor
ALDER BIOPHARMACEUTICALS, INC
Executed: 2019-11-04
Assignee
LUNDBECK SEATTLE BIOPHARMACEUTICALS, INC
11804 NORTH CREEK PARKWAY SOUTH,, BOTHELL, WASHINGTON, 98011
Covered Properties
(77)
Methods of Synthesizing Heteromultimeric Polypeptides in Yeast Using a Haploid Mating Strategy
Methods of Synthesizing Heteromultimeric Polypeptides in Yeast Using a Haploid Mating Strategy
Novel P. Pastoris Adh Promoter and Use Thereof to Direct Expression of Proteins
Antibodies to Il-6 and Use Thereof
Antagonists of Il-6 to Prevent or Treat Cachexia, Weakness, Fatigue, and/or Fever
Antagonists of Il-6 to Prevent or Treat Thrombosis
Antibodies to Il-6 and Use Thereof
Treating Anemia Using Il-6 Antibodies Having Particular Epitopic Specificity
Application:
12/601,295 →
Publication:
US 2010/0290993
Methods of Treating or Diagnosing Conditions Associated with Elevated Il-6 Using Anti-Il-6 Antibodies or Fragments
Methods of Treating Anemia Using Anti-Il-6 Antibodies
Antagonists of Il-6 to Prevent or Treat Thrombosis
Antagonists of Il-6 to Raise Albumin and/or Lower Crp
Antagonists of Il-6 to Prevent or Treat Cachexia, Weakness, Fatigue, and/or Fever
Methods of synthesizing heteromultimeric polypeptides in yeast using a haploid mating strategy
Anti-Il-6 Antibodies for the Treatment of Oral Mucositis
Anti-Il-6 Antibodies for the Treatment of Arthritis
Anti-Il-6 Antibodies for the Treatment of Anemia
Anti-IL-6 antibodies or fragments thereof to treat or inhibit cachexia, associated with chemotherapy toxicity
Antagonists of Il-6 to Prevent or Treat Thrombosis
Subcutaneously Administrable Composition Containing Anti-Il-6 Antibody
Antagonists of Il-6 to Prevent or Treat Thrombosis
Methods of Synthesizing Heteromultimeric Polypeptides in Yeast Using a Haploid Mating Strategy
Antagonists of Il-6 to Prevent or Treat Thrombosis
Antagonists of Il-6 to Treat Cachexia, Weakness, Fatigue , and/or Fever
Antibodies to Il-6 to Inhibit or Treat Inflammation
Antagonists of IL-6 to raise albumin and/or lower crp
Methods of Synthesizing Heteromultimeric Polypeptides in Yeast Using a Haploid Mating Strategy
Antibody Purification and Purity Monitoring
Temperature Shift for High Yield Expression of Polypeptides in Yeast and Other Transformed Cells
Protocol for Identifying and Isolating Antigen-Specific B Cells and Producing Antibodies to Desired Antigens
Application:
14/217,594 →
Publication:
US 2014/0287952
A Method of Improving Patient Survivability and Quality of Life by Administering an Anti-Il-6 Antibody
Treating Anemia in Chronic Il-6 Associated Diseases Using Anti-Il-6 Antibodies
Anti-Acth Antibodies and Use Thereof
Anti-Il-6 Antibodies for the Treatment of Oral Mucositis
Anti-Il-6 Antibody for Use in the Treatment of Cachexia
Isolated Anti-Il-6 Antibodies
Antagonists of Il-6 to Prevent or Treat Thrombosis
Antibodies to Il-6 and Use Thereof
Temperature Shift for High Yield Expression of Polypeptides in Yeast and Other Transformed Cells
Protocol for Identifying and Isolating Antigen-Specific B Cells and Producing Antibodies to Desired Antigens
Application:
14/776,945 →
Publication:
US 2016/0033504
Antagonists of Il-6 to Prevent or Treat Cachexia, Weakness, Fatigue, and/or Fever
Methods of Synthesizing Heteromultimeric Polypeptides in Yeast Using a Haploid Mating Strategy
Antagonists of Il-6 to Prevent or Treat Thrombosis
Humanized Anti-Acth Antibodies and Use Thereof
Antagonists of Il-6 to Raise Albumin and/or Lower Crp
Use of Anti-Pacap Antibodies and Antigen Binding Fragments Thereof for Treatment, Prevention, or Inhibition of Photophobia
Anti-Pacap Antibodies
Application:
15/130,263 →
Publication:
US 2016/0362488
Use of Anti-Pacap Antibodies and Antigen Binding Fragments Thereof for Treatment, Prevention, or Inhibition of Photophobia
Application:
15/130,658 →
Publication:
US 2016/0376363
Anti-Pacap Antibodies
Antibody Purification and Purity Monitoring
Antagonists of Il-6 to Prevent or Treat Cachexia, Weakness, Fatigue, and/or Fever
Anti-Pacap Antibodies and Uses Thereof
Humanized Anti-Pacap Antibodies and Uses Thereof
Anti-Glycoprotein Antibodies and Uses Thereof
Application:
15/544,163 →
Publication:
US 2018/0142038
Anti-Acth Antibodies and Use Thereof
Antagonists of Il-6 to Raise Albumin and/or Lower Crp
Methods of Treating Autoimmunity Using Specific Anti-Il-6 Antibodies
Anti-Il-6 Antibodies for the Treatment of Arthritis
Method of Treating Allergic Asthma with Antibodies to Il-6
Antagonists of Il-6 to Prevent or Treat Cachexia, Weakness, Fatigue, and/or Fever
Application:
15/797,209 →
Publication:
US 2018/0117149
Antagonists of Il-6 to Prevent or Treat Thrombosis
Anti-Il-6 Antibodies for the Treatment of Oral Mucositis
Application:
15/951,337 →
Publication:
US 2019/0023780
Humanized Anti-Acth Antibodies and Use Thereof
Antagonists of Il-6 to Prevent or Treat Thrombosis
Pichia Pastoris Yeast Cultures Comprising Reduced Antibody-Associated Variants
Antagonists of Il-6 to Prevent or Treat Cachexia, Weakness, Fatigue, and/or Fever
Application:
16/191,514 →
Publication:
US 2019/0270805
Methods of Determining Whether Anti-Pacap Antibodies Inhibit Pacap-Associated Photophobia or Light Aversion
Anti-Pacap Antibodies
Temperature Shift for High Yield Expression of Polypeptides in Yeast and Other Transformed Cells
Anti-Pacap Antibodies and Uses Thereof
Methods of Synthesizing Heteromultimeric Polypeptides in Yeast Using a Haploid Mating Strategy
Antibodies to Il-6 and Use Thereof
Application:
16/550,625 →
Publication:
US 2020/0108140
Antagonists of Il-6 to Raise Albumin and/or Lower Crp
Application:
16/591,668 →
Publication:
US 2020/0093921
Humanized Anti-Acth Antibodies and Use Thereof
Humanized Anti-Pacap Antibodies
Humanized Anti-Pacap Antibodies
Humanized Anti-Pacap Antibodies
Related Assignments
(18)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jan 12, 2010
From: GARCIA-MARTINEZ, LEON; JENSEN, ANNE ELIZABETH CARVALHO; OLSON, KATIE; DUTZAR, BEN
To: ALDER BIOPHARMACEUTICALS, INC.
Reel/Frame 023763/0347 →
Corrective Assignment to Correct the Assignee's Name in Non-Us Cases Only Previously Recorded on Reel 025681 Frame 0634. Assignor(S) Hereby Confirms the Conveyance of Non-Us Rights of Patents Relating to Applications Listed in Assignment..
Nov 28, 2012
From: ALDERBIO HOLDINGS LLC
To: BRISTOL-MYERS SQUIBB COMPANY
Reel/Frame 029372/0056 →
Assignment of Assignor's Interest
Dec 26, 2013
From: SMITH, JEFFREY T.L.; SCHATZMAN, RANDALL C; LITTON, MARK J; LATHAM, JOHN
To: ALDER BIOPHARMACEUTICALS, INC.
Reel/Frame 031848/0494 →
Corrective Assignment to Correct the the Second Assignor's Name to Correctly Read Carvalho Jensen, Anne Elisabeth Previously Recorded on Reel 022155 Frame 0247. Assignor(S) Hereby Confirms the Assignment of Assignors' Interest.
Feb 5, 2014
From: GARCIA-MARTINEZ, LEON; CARVALHO JENSEN, ANNE ELISABETH; OLSON, KATIE; DUTZAR, BEN
To: ALDER BIOPHARMACEUTICALS, INC.
Reel/Frame 032161/0840 →
Corrective Assignment to Correct the Second Assignor's Name to Correctly Read Carvalho Jensen, Anne Elisabeth Previously Recorded on Reel 024029 Frame 0749. Assignor(S) Hereby Confirms the Assignment of Assignors' Interest.
Feb 5, 2014
From: GARCIA-MARTINEZ, LEON; CARVALHO JENSEN, ANNE ELISABETH; OLSON, KATIE; DUTZAR, BEN
To: ALDER BIOPHARMACEUTICALS, INC.
Reel/Frame 032161/0983 →
Corrective Assignment to Correct the Spelling of Inventor Anne Elisabeth Carvalho Jensen's Name Previously Recorded on Reel 023763 Frame 0347. Assignor(S) Hereby Confirms the Assignment of Assignors' Interest.
Feb 5, 2014
From: GARCIA-MARTINEZ, LEON; CARVALHO JENSEN, ANNE ELISABETH; OLSON, KATIE; DUTZAR, BEN
To: ALDER BIOPHARMACEUTICALS, INC.
Reel/Frame 032231/0411 →
Assignment of Assignor's Interest
Feb 7, 2014
From: CREGG, JAMES M.; LATHAM, JOHN; LITTON, MARK; SCHATZMAN, RANDALL
To: KECK GRADUATE INSTITUTE; ALDER BIOPHARMACEUTICALS, INC.
Reel/Frame 032172/0723 →
Assignment of Assignor's Interest
Feb 24, 2014
From: BRISTOL-MYERS SQUIBB COMPANY
To: ALDERBIO HOLDINGS LLC
Reel/Frame 032329/0931 →
Assignment of Assignor's Interest
Feb 25, 2014
From: ALDER BIOPHARMACEUTICALS, INC.
To: ALDERBIO HOLDINGS LLC
Reel/Frame 032289/0791 →
Assignment of 1/2 Interest in Non-U.S. Applications
Feb 25, 2014
From: ALDERBIO HOLDINGS LLC
To: BRISTOL-MYERS SQUIBB COMPANY
Reel/Frame 032332/0787 →
Assignment of Assignor's Interest
Dec 12, 2014
From: BRISTOL-MYERS SQUIBB COMPANY
To: ALDERBIO HOLDINGS LLC
Reel/Frame 034491/0663 →
Assignment of Assignor's Interest
Jan 16, 2015
From: BRISTOL-MYERS SQUIBB COMPANY
To: ALDERBIO HOLDINGS LLC
Reel/Frame 034777/0728 →
Change of Name
Jun 23, 2020
From: ALDER BIOPHARMACEUTICALS, INC.
To: LUNDBECK SEATTLE BIOPHARMACEUTICALS, INC.
Reel/Frame 053020/0143 →
Assignment of Assignor's Interest
Jun 23, 2020
From: ALDERBIO HOLDINGS LLC
To: H. LUNDBECK A/S
Reel/Frame 053020/0331 →
Assignment of Assignor's Interest
Jun 23, 2020
From: LUNDBECK SEATTLE BIOPHARMACEUTICALS, INC
To: H. LUNDBECK A/S
Reel/Frame 053020/0205 →
Assignment of Assignor's Interest
Aug 14, 2020
From: H. LUNDBECK A/S
To: VITAERIS INC.
Reel/Frame 053496/0319 →
Assignment of Assignor's Interest
Sep 3, 2020
From: LUNDBECK SEATTLE BIOPHARMACEUTICALS, INC
To: H. LUNDBECK A/S.
Reel/Frame 054161/0877 →
Corrective Assignment to Correct the Assignee Name Previously Recorded at Reel: 054161 Frame: 0877. Assignor(S) Hereby Confirms the Assignment.
Jun 2, 2021
From: LUNDBECK SEATTLE BIOPHARMACEUTICALS, INC
To: H. LUNDBECK A/S
Reel/Frame 056449/0543 →